Pharmacokinetics of ceftolozane/tazobactam continuous infusion on renal replacement therapy : A pediatric case report
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:77 |
|---|---|
| Enthalten in: |
Therapie - 77(2022), 5 vom: 01. Sept., Seite 616-620 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Collignon, Charlotte [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 03.10.2022 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.therap.2021.10.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM33314015X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM33314015X | ||
| 003 | DE-627 | ||
| 005 | 20231225221031.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.therap.2021.10.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1110.xml |
| 035 | |a (DE-627)NLM33314015X | ||
| 035 | |a (NLM)34776252 | ||
| 035 | |a (PII)S0040-5957(21)00208-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Collignon, Charlotte |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pharmacokinetics of ceftolozane/tazobactam continuous infusion on renal replacement therapy |b A pediatric case report |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.10.2022 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Ceftolozane/tazobactam | |
| 650 | 4 | |a Continuous hemodiafiltration | |
| 650 | 4 | |a Pediatric | |
| 650 | 4 | |a Pharmacokinetics | |
| 650 | 4 | |a Therapeutic drug monitoring | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Cephalosporins |2 NLM | |
| 650 | 7 | |a ceftolozane, tazobactam drug combination |2 NLM | |
| 650 | 7 | |a ceftolozane |2 NLM | |
| 650 | 7 | |a 37A4IES95Q |2 NLM | |
| 650 | 7 | |a Tazobactam |2 NLM | |
| 650 | 7 | |a SE10G96M8W |2 NLM | |
| 700 | 1 | |a Gana, Ines |e verfasserin |4 aut | |
| 700 | 1 | |a Benaboud, Sihem |e verfasserin |4 aut | |
| 700 | 1 | |a Toubiana, Julie |e verfasserin |4 aut | |
| 700 | 1 | |a Castelle, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Oualha, Mehdi |e verfasserin |4 aut | |
| 700 | 1 | |a de Marcellus, Charles |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Therapie |d 1947 |g 77(2022), 5 vom: 01. Sept., Seite 616-620 |w (DE-627)NLM000023655 |x 1958-5578 |7 nnns |
| 773 | 1 | 8 | |g volume:77 |g year:2022 |g number:5 |g day:01 |g month:09 |g pages:616-620 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.therap.2021.10.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 77 |j 2022 |e 5 |b 01 |c 09 |h 616-620 | ||